Eye News and Research

Latest Eye News and Research

Mediaplanet releases Kidney Health report to targeted markets in USA

On April 29, 2011, Mediaplanet Publishing released a Kidney Health report to targeted markets in USA Today. The report will be distributed to 1 million readers with contributions from Kidney Cancer Association, National Kidney Foundation, Fresenius Medical Care North America, UKidney, Medical Education Institute, and National Kidney Registry.

30 Apr 2011

Gene therapy approach using CD59 shows promise against AMD: Study

A gene therapy approach using a protein called CD59, or protectin, shows promise in slowing the signs of age-related macular degeneration, according to a new in vivo study by researchers at Tufts University School of Medicine.

30 Apr 2011

Avastin, Lucentis are equally effective for age-related macular degeneration treatment

Age-related macular degeneration, a disease that damages the retina and can destroy central vision, affects approximately 1.6 million Americans. For the past five years, there has been active debate over treatment options for AMD patients because ophthalmologists have not had accurate data regarding the true efficacy of the most commonly used medication.

29 Apr 2011

Researchers report Avastin is effective as Lucentis for AMD treatment

Researchers are reporting results from the first year of a two-year clinical trial that Avastin, a drug approved to treat some cancers and that is commonly used off-label to treat age-related macular degeneration, is as effective as the Food and Drug Administration-approved drug Lucentis for the treatment of AMD.

29 Apr 2011

5 minute Autism detection test

According to a study published Thursday, a brief screening in a pediatrician's office can detect autism-like symptoms in children as young as 12 months old, giving them an important head start on treatment. The screening test used in the study also flagged some babies who later turned out to be developing normally, raising a false alarm for families. But early diagnosis and treatment of autism and other developmental delays are thought to improve outcomes, and researchers said the benefits of early intervention outweighed the downsides.

29 Apr 2011

STAAR Surgical receives CE Mark approval for nanoFLEX Collamer IOL lens

STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced CE Mark approval for its nanoFLEX Collamer Single Piece IOL which can be injected through a 2.2 mm incision with the nanoPOINT Injector System.

28 Apr 2011

E-Cigarette company welcomes FDA regulation

The recent ruling in the Sottera, Inc. v. Food & Drug Administration case has once again brought the E-Cigarette industry into the spotlight and Green Nicotine Electronic Cigarettes could not be better prepared. Many electronic cigarette companies will have to scramble to prepare for FDA regulation, but Green Nicotine Electronic Cigarettes has been prepared for these types of regulations since 2009.

28 Apr 2011

Molecular Partners completes MP0112 phase I/IIa trials in wet AMD, DME

Molecular Partners AG, a leader in the development of next generation therapeutics, announced today that it has completed two phase I/IIa clinical trials with MP0112, its lead molecule targeting VEGF-A.

28 Apr 2011

Five-minute screening program can help track children with autism

A five-minute checklist that parents can fill out in pediatrician waiting rooms may someday help in the early diagnosis of autism spectrum disorder, according to a study funded by the National Institutes of Health.

28 Apr 2011

Novel strategy for physicians to detect Autism Syndrome Disorder in babies

A novel strategy developed by autism researchers at the University of California, San Diego School of Medicine, called "The One-Year Well-Baby Check Up Approach," shows promise as a simple way for physicians to detect cases of Autism Syndrome Disorder, language or developmental delays in babies at an early age.

28 Apr 2011

Dems eye Ryan Medicare plan as political opportunity

With Obama administration officials part of the campaign against the Ryan plan, other opponents also are stepping forward and launching a new wave of television ads in Wisconsin Republican Rep. Paul Ryan's very own congressional district. Meanwhile, The Washington Post analyzes some of the poll numbers behind where voters may stand on Medicare cuts.

27 Apr 2011

Viewpoints: Shortsighted fight against fund to prevent disease; strengthening regulators' control of premium increases

House Republicans are so bent on blocking any and all aspects of health care reform that they have passed a bill that would eliminate a farsighted program — the Prevention and Public Health Fund — intended to help states and communities prevent diseases. Eliminating the fund would save roughly $16 billion over the course of a decade. … The loss to states and local communities would be considerable.

27 Apr 2011

Too much TV raises risk of narrow eye blood vessels and heart disease in kids

A new study has shown that children who spend more time in front of television and computer screens and less in outdoor physical activity have narrower blood vessels in their eyes. In adults, constricted blood vessels in the eyes have been linked to an increased risk of cardiovascular disease.

26 Apr 2011

LCA-Vision reports first profitable quarter in three years

LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, today announced financial and operational results for the three months ended March 31, 2011.

26 Apr 2011

TMC RNs issue formal notice to hold one-day strike for patient safety

The Tufts Medical Center registered nurses' negotiating committee tonight issued an official notice of their intent to hold a one-day strike to protest dangerous patient care conditions on Friday, May 6, 2011. The strike will be the first nurses' strike at a Boston hospital in more than 25 years.

26 Apr 2011

Researchers report game-changing advance in stem cell science

In a paper published in the April 25 early online edition of the Proceedings of the National Academy of Sciences, researchers at the University of California, San Diego School of Medicine, the Gladstone Institutes in San Francisco and colleagues report a game-changing advance in stem cell science: the creation of long-term, self-renewing, primitive neural precursor cells from human embryonic stem cells that can be directed to become many types of neuron without increased risk of tumor formation.

26 Apr 2011